TRC105 (anti-endoglin antibody) in combination with bevacizumab (BEV) and as a single agent for platinum resistant ovarian cancer Meeting Abstract
| Authors: | Garcia, A. A.; Makker, V.; Spitz, D. L.; Matei, D. E.; Nick, A. M.; Landen, C. N.; Alvarez, E. A.; Mendelson, D. S.; Strother, R. M.; Seon, B. K.; Alvarez, D.; Adams, B. J.; Theuer, C. P.; Gordon, M. |
| Abstract Title: | TRC105 (anti-endoglin antibody) in combination with bevacizumab (BEV) and as a single agent for platinum resistant ovarian cancer |
| Meeting Title: | 39th ESMO Congress (ESMO 2014) |
| Journal Title: | Annals of Oncology |
| Volume: | 25 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2014 Sep 26-30 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2014-09-01 |
| Start Page: | iv310 |
| Language: | English |
| ACCESSION: | WOS:000346901000262 |
| DOI: | 10.1093/annonc/mdu338.13 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 887P -- Source: Wos |
